comparemela.com

Latest Breaking News On - எல்லை பார்மா - Page 1 : comparemela.com

Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia

Press release content from PR Newswire. The AP news staff was not involved in its creation. Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia April 1, 2021 GMT LONDON and BELGRADE, Serbia, April 1, 2021 /PRNewswire/ Frontier Pharma and Baystone Group today announced the completion of its acquisition of Zdravlje A.D from Teva Pharmaceuticals. Zdravlje currently supplies high quality pharmaceuticals to more than 35 international markets including those in Western & Eastern Europe, U.K., Asia-Pacific, Sub-Saharan Africa and Latin America. “We are incredibly pleased to complete this transaction and support Zdravlje as a leading independent pharmaceutical company. We look forward to working together with the exceptionally talented team at Zdravlje to further develop the Company into a leading international pharmaceutical company.” said M. Levent Selamoglu, Chairman of Frontier Pharma.

Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia

Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Frontier Pharma and Baystone Group acquire Serbian pharmaceutical company Zdravlje

Frontier Pharma and Baystone Group acquire Serbian pharmaceutical company Zdravlje 12/01/2021 Britain’s Frontier Pharma and the Baystone investment group have acquired Serbian pharmaceuticals company Zdravlje Leskovac, its owner’s Serbia-based business said in a statement on Monday. The statement did not specify the price paid for the takeover of the drugmaker, which is owned by Actavis, a subsidiary of Israeli company Teva. Teva took control of Zdravlje Leskovac through its acquisition of Actavis in 2016. “Our intention is to closely cooperate with Teva during this transition and to … in time develop the (Zdravlje Leskovac) company,” the statement said, citing Levent Selamoglu, Frontier Pharma’s chairman.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.